Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - NET INCOME
Net Income HALO - Halozyme Therapeutics, Inc.
282 M
LAST VALUE
-16.38%
2 YEAR CAGR
40.66%
5 YEAR CAGR
18.31%
10 YEAR CAGR